People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Addex Therapeutics Ltd. | — | Biotechnology | Series A | $13.9M | $35.7M | 2021 |
Robert Lutjens at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Lutjens on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jake Nunn | 1 | 5 |
| Raymond Hill | 1 | 2 |
| Jean-Philippe Rocher | 1 | 1 |
| Vincent Lawton | 1 | 1 |
| Mikhail Kalinichev | 1 | 1 |
| Timothy Dyer | 1 | 1 |
| Isaac Manke | 1 | 1 |
| Roger Mills | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.